» Authors » Nicholas Sanderson

Nicholas Sanderson

Explore the profile of Nicholas Sanderson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 454
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lees E, Gentry J, Webster H, Sanderson N, Eyre D, Wilson D, et al.
Microb Genom . 2025 Jan; 11(1. PMID: 39773387
The NRCS-A strain has emerged as a global cause of late-onset sepsis associated with outbreaks in neonatal intensive care units (NICUs) whose transmission is incompletely understood. Demographic and clinical data...
2.
Cane J, Sanderson N, Barnett S, Vaughan A, Pott M, Kapel N, et al.
J Infect . 2024 May; 88(6):106164. PMID: 38692359
Objectives: We evaluated Nanopore sequencing for influenza surveillance. Methods: Influenza A and B PCR-positive samples from hospital patients in Oxfordshire, UK, and a UK-wide population survey from winter 2022-23 underwent...
3.
Ulutekin C, Galli E, Schreiner B, Khademi M, Callegari I, Piehl F, et al.
Cell Rep Med . 2023 Dec; 5(1):101351. PMID: 38134930
Multiple sclerosis is a chronic inflammatory disease of the central nervous system. Whereas T cells are likely the main drivers of disease development, the striking efficacy of B cell-depleting therapies...
4.
Kotanidis C, Xie C, Alexander D, Rodrigues J, Burnham K, Mentzer A, et al.
Lancet Digit Health . 2022 Aug; 4(10):e705-e716. PMID: 36038496
Background: Direct evaluation of vascular inflammation in patients with COVID-19 would facilitate more efficient trials of new treatments and identify patients at risk of long-term complications who might respond to...
5.
Diebold M, Galli E, Kopf A, Sanderson N, Callegari I, Ingelfinger F, et al.
Ann Neurol . 2022 Feb; 91(5):676-681. PMID: 35170072
Treatment with dimethyl fumarate (DMF) leads to lymphopenia and infectious complications in a subset of patients with multiple sclerosis (MS). Here, we aimed to reveal immune markers of DMF-associated lymphopenia....
6.
Lumley S, Constantinides B, Sanderson N, Rodger G, Street T, Swann J, et al.
J Infect . 2021 Jul; 83(4):473-482. PMID: 34332019
Objectives: Despite robust efforts, patients and staff acquire SARS-CoV-2 infection in hospitals. We investigated whether whole-genome sequencing enhanced the epidemiological investigation of healthcare-associated SARS-CoV-2 acquisition. Methods: From 17-November-2020 to 5-January-2021,...
7.
Lumley S, Rodger G, Constantinides B, Sanderson N, Chau K, Street T, et al.
Clin Infect Dis . 2021 Jul; 74(7):1208-1219. PMID: 34216472
Background: Natural and vaccine-induced immunity will play a key role in controlling the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. SARS-CoV-2 variants have the potential to evade natural and...
8.
Lipworth S, Pickford H, Sanderson N, Chau K, Kavanagh J, Barker L, et al.
Microb Genom . 2020 Nov; 6(11). PMID: 33174830
Hybrid assemblies are highly valuable for studies of due to their ability to fully resolve the structure of mobile genetic elements, such as plasmids, which are involved in the carriage...
9.
Keep S, Oade M, Lidzbarski-Silvestre F, Bentley K, Stevenson-Leggett P, Freimanis G, et al.
J Gen Virol . 2020 Jul; 101(10):1103-1118. PMID: 32720890
Coronavirus sub-genomic mRNA (sgmRNA) synthesis occurs via a process of discontinuous transcription involving complementary transcription regulatory sequences (TRSs), one (TRS-L) encompassing the leader sequence of the 5' untranslated region (UTR),...
10.
Lewandowski K, Xu Y, Pullan S, Lumley S, Foster D, Sanderson N, et al.
J Clin Microbiol . 2019 Nov; 58(1). PMID: 31666364
Influenza is a major global public health threat as a result of its highly pathogenic variants, large zoonotic reservoir, and pandemic potential. Metagenomic viral sequencing offers the potential for a...